A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma.
Correale P, Messinese S, Caraglia M, Marsili S, Piccolomini A, Petrioli R, Ceciarini F, Micheli L, Nencini C, Neri A, Vuolo G, Guarnieri A, Abbruzzese A, Prete SD, Giorgi G, Francini G.
Correale P, et al. Among authors: nencini c.
Br J Cancer. 2004 May 4;90(9):1710-4. doi: 10.1038/sj.bjc.6601783.
Br J Cancer. 2004.
PMID: 15150625
Free PMC article.
Clinical Trial.